A Prospective, Randomized, Two Group Comparison Study to Evaluate the Effect of Statin [HMG-CoA reductase inhibitors] on Heart Function in Patients With Chronic Ischemic Heart Failure.

Trial Profile

A Prospective, Randomized, Two Group Comparison Study to Evaluate the Effect of Statin [HMG-CoA reductase inhibitors] on Heart Function in Patients With Chronic Ischemic Heart Failure.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2014

At a glance

  • Drugs Pitavastatin (Primary) ; Pravastatin
  • Indications Chronic heart failure; Ischaemic heart disorders
  • Focus Therapeutic Use
  • Acronyms SAPHIRE
  • Sponsors JW Pharmaceutical
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 13 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 04 Oct 2012 Planned End Date changed from 1 Dec 2010 to 1 Jan 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top